CLYDESDALE SPINAL SYSTEM
Report
- Report Number
- 1030489-2014-03342
- Event Type
- Injury
- Date Received
- July 29, 2014
- Report Date
- July 4, 2014
- Manufacturer
- MEDTRONIC SOFAMOR DANEK DEGGENDORF GMBH
- Product Code
- MAX
- PMA / PMN Number
- K100175
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- PHYSICIAN
Narratives
(B)(4): NEITHER DEVICE NOR APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MANUFACTURER FOR EVALUATION.
IT WAS REPORTED IN A LITERATURE ABSTRACT THAT A STUDY WAS CONDUCTED WHICH INCLUDED 7 PATIENTS (1 MAN, 6 WOMEN; MEAN AGE AT SURGERY, 64 YEARS) WHO UNDERWENT OLIF IN OR AFTER JULY 2013. OF THE PATIENTS, 2 HAD MULTIPLY OPERATED BACK AND 5 HAD SPINAL DEFORMITY. OLIF WAS PERFORMED AT A SINGLE (N=1), DUAL (N=2) OR TRIPLE (N=4) LEVEL(S). THE TREATED INTERVERTEBRAL LEVELS WERE T12/L1 (N=1), L1/2 (N=4), L3/4 (N=4), L2/3 (N=6), AND L4/5 (N=2, EACH PERFORMED TWICE). IN ALL CASES, OLIF WAS FOLLOWED BY FIXATION WITH SPINAL INSTRUMENTATION VIA POSTERIOR APPROACH. THE MEAN OPERATIVE TIME WAS 7 HOURS AND 55 MINUTES. THE MEAN BLOOD LOSS WAS 1322ML. THE 2 PATIENTS WITH LUMBER DEGENERATIVE DISEASE HAD LEG PAIN/NUMBNESS ASSOCIATED WITH INTERVERTEBRAL INSTABILITY BEFORE THE SURGERY, BUT THE LEG SYMPTOMS WERE IMPROVED POSTOPERATIVELY WITHOUT SURGERY OF THE INTRA-SPINAL CANAL. IN THE 5 PATIENTS WITH SPINAL DEFORMITY, THE MEAN COBB ANGLE OF THE TREATED INTERVERTEBRAL LEVELS CHANGED FROM 33°AT PRE-OP. TO 15°AFTER OLIF ALONE (CORRECTION RATE, 51%) AND TO 8°AT POST-OP. (CORRECTION RATE, 74%). MEANWHILE, THE MEAN KYPHOSIS OF THE OLIF OPERATED LEVELS MEASURED ON THE SAGITTAL PLANE WAS 11°AT PRE-OP, 5°AFTER OLIF DURING THE SURGERY, AND 8°AT POST-OP. COMPLICATIONS INCLUDED EPIDURAL HEMATOMA TREATED WITH FURTHER SURGERY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 442241 | CLYDESDALE SPINAL SYSTEM | INTERVERTEBRAL FUSION DEVICE WITH BONE GRAFT, LUMBAR | MAX | MEDTRONIC SOFAMOR DANEK DEGGENDORF GMBH | NA | UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 00064 YR | Required Intervention |